Literature DB >> 22696636

M pneumoniae infection, pulmonary thromboembolism and antiphospholipid antibodies.

Elia Ascer1, Marcus Marques, Magnus Gidlund.   

Abstract

A 28-year-old, hypertensive and hypercholesterolaemic patient, was referred to our emergency unit with a mild thoracic pain, productive cough and a body temperature of 37.3°C. Laboratory examinations showed normal white cell count and moderate elevation of C reactive protein (CRP). Later, the thoracic pain increased accompanied by shortness of breath. High D-dimer was detected. Positive lupic anticoagulant factor and anticardiolipin and antibodies anti-Mycoplasma pneumoniae were present and high titres of antinuclear factor. Recombinant tissue-type plasminogen activator plus heparin and vancomycin were administered due the high possibility of mycoplasma pneumonia associated with pulmonary thromboembolism. CRP increased to very high levels with very mild modification of white blood cells during the evolution. Thoracic tomography and pulmonary scintigraphy of the lungs confirmed the diagnosis. The patient responded well and he was discharged after 25 days medicated with hydroxychloroquine sulphate, warfarin and aspirin. At present date he is well (150 days).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22696636      PMCID: PMC3082067          DOI: 10.1136/bcr.12.2010.3561

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

Review 1.  Diagnosis and management of the antiphospholipid syndrome.

Authors:  Danielle Cohen; Stefan P Berger; Gerda M Steup-Beekman; Kitty W M Bloemenkamp; Ingeborg M Bajema
Journal:  BMJ       Date:  2010-05-14

Review 2.  Antiphospholipid syndrome dilemmas still to be solved: 2008 status.

Authors:  Yehuda Shoenfeld; Pier Luigi Meroni; Ricard Cervera
Journal:  Ann Rheum Dis       Date:  2008-04       Impact factor: 19.103

Review 3.  Antiphospholipid syndrome: frequency, main causes and risk factors of mortality.

Authors:  Gerard Espinosa; Ricard Cervera
Journal:  Nat Rev Rheumatol       Date:  2010-04-13       Impact factor: 20.543

Review 4.  [Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations].

Authors:  A Tincani; C Casu; S Cartella; T Ziglioli; R Cattaneo
Journal:  Reumatismo       Date:  2010 Jan-Mar

Review 5.  [Laboratory examinations in antiphospholipid syndrome].

Authors:  Masahiro Ieko; Sumiyoshi Naito; Mika Yoshida
Journal:  Rinsho Byori       Date:  2010-04

Review 6.  Pulmonary manifestations of the antiphospholipid antibody syndrome.

Authors:  H James Ford; Robert A S Roubey
Journal:  Clin Chest Med       Date:  2010-09       Impact factor: 2.878

Review 7.  Antiphospholipid syndrome (APS): where does it come from?

Authors:  Yaniv Sherer; Miri Blank; Yehuda Shoenfeld
Journal:  Best Pract Res Clin Rheumatol       Date:  2007-12       Impact factor: 4.098

Review 8.  Biomarkers and venous thromboembolism.

Authors:  Ingrid Pabinger; Cihan Ay
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03       Impact factor: 8.311

  8 in total
  3 in total

Review 1.  Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant).

Authors:  Claudia Mendoza-Pinto; Mario García-Carrasco; Ricard Cervera
Journal:  Curr Rheumatol Rep       Date:  2018-08-20       Impact factor: 4.592

Review 2.  Systematic review of case reports of antiphospholipid syndrome following infection.

Authors:  N Abdel-Wahab; M A Lopez-Olivo; G P Pinto-Patarroyo; M E Suarez-Almazor
Journal:  Lupus       Date:  2016-04-07       Impact factor: 2.911

3.  A Case of Miller Fisher Syndrome, Thromboembolic Disease, and Angioedema: Association or Coincidence?

Authors:  Nooshin Salehi; Eric D Choi; Roger C Garrison
Journal:  Am J Case Rep       Date:  2017-01-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.